Literature DB >> 18068784

Imaging appearances following thermal ablation.

S Smith1, A Gillams.   

Abstract

Radiofrequency ablation (RFA) has an increasingly important role in the management of a number of solid tumours. Treatments usually take place at specialist centres that draw patients from a wide geographical area, but follow-up imaging is often undertaken at the referring institution. This review aims to describe and illustrate the range of normal and abnormal post-ablative appearances encountered in the most commonly treated organs, i.e. liver, lung, and kidney, to equip radiologists with the necessary knowledge for confident interpretation of post-ablation imaging in this diverse patient group.

Entities:  

Mesh:

Year:  2007        PMID: 18068784     DOI: 10.1016/j.crad.2007.06.002

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  10 in total

1.  Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time.

Authors:  Aymeric Guibal; Caroline Bertin; Sophie Egels; Eric Savier; Philippe A Grenier; Olivier Lucidarme
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

2.  An overview of image-guided percutaneous ablation of renal tumors.

Authors:  Majid Maybody
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

3.  Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.

Authors:  S Tokunaga; M Koda; T Matono; T Sugihara; T Nagahara; M Ueki; Y Murawaki; S Kakite; E Yamashita
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

4.  CT-guided percutaneous cryoablation of central lung tumors.

Authors:  Errol Colak; Servet Tatlı; Paul B Shyn; Kemal Tuncalı; Stuart G Silverman
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

5.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

6.  Dual-energy CT after radiofrequency ablation of liver, kidney, and lung lesions: a review of features.

Authors:  Frederik Vandenbroucke; Steven Van Hedent; Gert Van Gompel; Nico Buls; Gordon Craggs; Jef Vandemeulebroucke; Pablo R Ros; Johan de Mey
Journal:  Insights Imaging       Date:  2015-05-05

Review 7.  Post Locoregional Therapy Treatment Imaging in Hepatocellular Carcinoma Patients: A Literature-based Review.

Authors:  Shamar Young; Andrew J Taylor; Tina Sanghvi
Journal:  J Clin Transl Hepatol       Date:  2018-02-14

8.  Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?

Authors:  Frederik Vandenbroucke; Jef Vandemeulebroucke; Nico Buls; Ruedi F Thoeni; Johan de Mey
Journal:  Int J Comput Assist Radiol Surg       Date:  2018-04-12       Impact factor: 2.924

9.  Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence.

Authors:  Petra G Kele; Eric J Van der Jagt; Paul F M Krabbe; Koert P de Jong
Journal:  Int J Hepatol       Date:  2012-12-24

10.  Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation.

Authors:  Constantinos T Sofocleous; Sandeep K Garg; Perry Cohen; Elena N Petre; Mithat Gonen; Joseph P Erinjeri; Robert J Downey; William D Travis; Stephen B Solomon
Journal:  Ann Surg Oncol       Date:  2013-07-30       Impact factor: 4.339

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.